| Period Ending: |
LTM
(Last Twelve Months) |
2024 12-31 |
2023 12-31 |
2022 12-31 |
2021 12-31 |
2020 12-31 |
2019 12-31 |
|---|---|---|---|---|---|---|---|
| Report Filing | 2025-10-30 | 2025-02-19 | 2024-02-26 | 2023-02-27 | 2022-03-25 | 2020-12-31 | 2019-12-31 |
| Revenue | 795.8 | 786.6 | 728.9 | 629.1 | 515.7 | 429.9 | 276.3 |
| Cost of Revenue | 278.2 | 294.6 | 309.6 | 275.3 | 236 | 209.3 | 143.5 |
| Gross Profit | 517.6 | 491.9 | 419.3 | 353.8 | 279.6 | 220.6 | 132.8 |
| Operating Expenses | 529.9 | 581.3 | 541.2 | 505 | 357.5 | 294 | 200.8 |
| Research & Development | 105.7 | 125.4 | 120.3 | 104.6 | 66.11 | 50.64 | 34.38 |
| Selling, General and Administrative | 417.2 | 439.1 | 410.6 | 400.4 | 291.4 | 243.4 | 166.5 |
| Other Operating Expenses | 6.99 | 16.68 | 10.26 | 0 | 0 | 0 | 0 |
| Operating Income | -12.32 | -89.33 | -121.9 | -151.2 | -77.91 | -73.38 | -68.03 |
| Net Non-Operating Interest | 14.5 | 19.29 | 20.15 | 4.3 | -0.016 | -1.15 | 0.087 |
| Interest Income | 15.03 | 19.67 | 20.67 | 5.55 | 0.016 | 0 | 0.087 |
| Interest Expense | 0.53 | 0.379 | 0.518 | 1.25 | 0.032 | 1.15 | 0 |
| Equity & Other Income/(Expense) | -1.08 | -10.9 | -1.9 | -4.7 | -0.92 | 0.055 | -0.384 |
| Income Before Tax | 1.11 | -80.94 | -103.6 | -151.6 | -78.84 | -74.47 | -68.33 |
| Income Tax Expense | 4.83 | 4.35 | 3.65 | 2.29 | 1.18 | 3.15 | 1.38 |
| Income Attributable to Non-Controlling Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income | -3.73 | -85.29 | -107.3 | -153.9 | -80.03 | -77.62 | -69.7 |
| Depreciation and Amortization | 25.19 | -0.069 | 24.59 | 21.22 | 15.3 | 11.05 | 8.74 |
| EBITDA | 12.87 | -89.4 | -97.31 | -130 | -62.61 | -62.33 | -59.29 |
| Earnings Per Share (EPS) | -0.025 | -0.56 | -0.71 | -1.09 | -0.56 | -0.56 | -2.17 |
| Diluted Earnings Per Share | -0.026 | -0.56 | -0.71 | -1.09 | -0.56 | -0.56 | -2.17 |
| Weighted Average Shares Outstanding | 149.9 | 151.3 | 150.1 | 140.9 | 139.2 | 139.6 | 32.1 |
| Diluted Weighted Average Shares Outstanding | 152 | 151.3 | 150.1 | 140.9 | 139.2 | 139.6 | 32.1 |
